Disc Medicine, Inc. Selling, General and Administrative Expense
Disc Medicine, Inc. (IRON) reported Selling, General and Administrative Expense of $18.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-30
- Disc Medicine, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $18.14M, a 20.22% increase year-over-year.
- Disc Medicine, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $23.62M, a 93.88% increase year-over-year.
- Disc Medicine, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $20.75M, a 112.71% increase year-over-year.
- Disc Medicine, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $17.36M, a 112.48% increase year-over-year.
- Disc Medicine, Inc. selling, general and administrative expense for fiscal 2025 was $65.38M, a 97.83% increase from fiscal 2024.
- Disc Medicine, Inc. selling, general and administrative expense for fiscal 2024 was $33.05M, a 51.18% increase from fiscal 2023.
- Disc Medicine, Inc. selling, general and administrative expense for fiscal 2023 was $21.86M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.14M 10-Q · filed 2026-07-30 | $41.76M 10-Q · filed 2026-07-30 | $62.51M derived: sum of 3 quarters · filed 2026-07-30 | $79.87M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $23.62M 10-Q · filed 2026-05-05 | $44.37M derived: sum of 2 quarters · filed 2026-05-05 | $61.73M derived: sum of 3 quarters · filed 2026-05-05 | $76.82M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $20.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $38.11M derived: sum of 2 quarters · filed 2026-02-26 | $53.20M derived: sum of 3 quarters · filed 2026-07-30 | $65.38M 10-K · filed 2026-02-26 |
| 2025-09-30 | $17.36M 10-Q · filed 2025-11-06 | $32.45M derived: sum of 2 quarters · filed 2026-07-30 | $44.64M 10-Q · filed 2025-11-06 | $54.39M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $15.09M 10-Q · filed 2026-07-30 | $27.27M 10-Q · filed 2026-07-30 | $37.03M derived: sum of 3 quarters · filed 2026-07-30 | $45.20M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $12.18M 10-Q · filed 2026-05-05 | $21.94M derived: sum of 2 quarters · filed 2026-05-05 | $30.11M derived: sum of 3 quarters · filed 2026-05-05 | $37.47M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $9.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $17.92M derived: sum of 2 quarters · filed 2026-02-26 | $25.29M derived: sum of 3 quarters · filed 2026-02-26 | $33.05M 10-K · filed 2026-02-26 |
| 2024-09-30 | $8.17M 10-Q · filed 2025-11-06 | $15.54M derived: sum of 2 quarters · filed 2025-11-06 | $23.30M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $7.37M 10-Q · filed 2025-08-07 | $15.13M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $7.76M 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $21.86M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |